Sort   by:  
 Page size 
TranscriptomicsComparison of wild type and DEK1 mutant juvenile gametophytic development in Physcomitrium (Physcomitrella) patens with RNAseq data
Physcomitrium (Physcomitrella) patens Gransden wild type strain and four mutants Δdek1 (Perroud et al., 2014); Δloop (Demko et al., 2014); Δlg3 (Johansen et al., 2016) and oex1 (this work) were sequenced for time series analysis.
ORGANISM(S): Physcomitrella patens 
2023-12-31 | E-MTAB-10907 | biostudies-arrayexpress
TranscriptomicsDEK1 deletion effect on Physcomitrella patens transcriptome
The main phenotype observed in DEK1 deletion (deltadek1) in P. patens is an absence of gametophore (leafy shoot) development. But, bud initiation the first step in gametophore development occurs. This experiments aims to compare transcriptome of wild-type and deltadek1 strains before budding onset,...
ORGANISM(S): Physcomitrella patens 
2014-10-22 | E-MTAB-2588 | biostudies-arrayexpress
UnknownObservational cohort study of rilpivirine (RPV) utilization in Europe.
Not available
S-EPMC9357334 | biostudies-literature
UnknownEffects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials.
Not available
S-EPMC10156140 | biostudies-literature
UnknownEffectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016-17 and 2017-18).
Not available
S-EPMC6807025 | biostudies-literature
UnknownCirculating HBV RNA and hepatitis B core-related antigen as determinants of HBsAg loss in persons with HIV in Europe.
Not available
S-EPMC12803887 | biostudies-literature
UnknownSafety of baricitinib in vaccinated patients with severe and critical COVID-19 sub study of the randomised Bari-SolidAct trial.
Not available
S-EPMC11743795 | biostudies-literature
UnknownEfficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial.
Not available
S-EPMC9830601 | biostudies-literature
UnknownIntensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial.
Not available
S-EPMC6652154 | biostudies-literature
UnknownLipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.
Not available
S-EPMC8822604 | biostudies-literature
Sort   by:  
 Page size